New Antibodies for COVID-19 Virus Detection

The nucleocapsid of COVID-19 virus is ideal for antigen detection for two major reasons:

1) It is produced abundantly in infected cells.

2) It is a highly conserved protein and therefore not prone to mutation.

The cytoplasm of infected cells fills with the nucleocapsid antigen. These cells can be collected on a NP swab and added to a specimen buffer to lyse and release this antigen for detection by immunoassay.

ViroStat has developed and just released a set of new monoclonal antibodies to the nucleocapsid of the COVID-19 virus. These final 5 antibodies were selected from an initial group of 60 based upon highest binding affinity and best ELISA pairing for detection of native viral antigen.

Download the data sheet for these new monoclonal antibodies. 

More information online